Posts by tag
biomarker testing
Time is of Essence
Europe has never had more powerful tools against cancer. But progress means little if patients cannot reach them in time. Cancer has never moved at the speed of bureaucracy. Today, science can identify molecular alterations that were once invisible. Biomarker…
The Ovation and the Asterisk
Five trials, five cancers, and what the ASCO 2026 plenary really promised patients ASCO 2026’s plenary delivered five real advances across five cancers, and a standing ovation that pulled a hall full of oncologists to their feet. The harder question…
Machine learning holds key to personalised cancer drugs
Researchers have developed a machine learning (ML) algorithm that can be used to rank the effectiveness of different drugs in reducing cancer cell growth for individual patients. In Nature Communications (25 March 2021), the UK investigators report the feasibility of…